Skip to main content

Insulin-like growth factor-1, growth hormone-dependent insulin-like growth factor-binding protein and growth in children with chronic renal failure

Abstract

Insulin-like growth factor-binding protein-3 (IGFBP-3) and insulin-like growth factor-1 (IGF-1) levels were measured by specific radioimmunoassays in children with all degrees of chronic renal failure (CRF). Study group 1 comprised 29 children (10 on dialysis) who had been studied one to four times over 2 years to determine whether IGF-1 and IGFBP-3 levels differed from those in age-matched healthy children and to examine the relationship between these levels and heights. IGF-1 and IGFBP-3 levels did not differ from those in normal children. IGF-1 and IGFBP-3 were significantly correlated, increased with pubertal stage in all children and with age in non-dialysis patients. IGF-1, but not IGFBP-3, correlated with age in dialysis patients. There was no correlation between IGF-1 or IGFBP-3 levels (corrected for age) and height standard deviation score (SDS) in either non-dialysis or dialysis patients. Study group 2 comprised 19 children (7 on dialysis) who were studied prospectively for 1–2 years to examine the relationship between IGF-1 and IGFBP-3 levels, growth rates and nutritional parameters. Mean values of IGF-1 and IGFBP-3 (corrected for age) did not change over 1-year periods, while height SDS fell by −0.38 ±0.21 SD/year in dialysis patients and by −0.11 ±0.29 SD/year in non-dialysis patients. No significant correlations were found between IGF-1 or IGFBP-3 levels and growth rates or nutritional parameters. Thus growth retardation in children with CRF is not related to circulating levels of IGF-1 or IGFBP-3.

This is a preview of subscription content, access via your institution.

References

  1. Hodson EM, Knight JF, Sheil AGR, Roy LP, Harris JP, Rogers JR, Stephen MS, Boulas J, Thompson JF, May J (1990) End stage renal failure in children: 16 years' experience at one Australian Centre. Med J Aust 152: 245–250

    Google Scholar 

  2. Chantler C (1988) Growth and metabolism in renal failure. The Teale Lecture 1987. J R Coll Physicians Lond 22: 69–73

    Google Scholar 

  3. El-Bishti MM, Counahan R, Bloom SR, Chantler C (1978) Hormonal and metabolic responses to intravenous glucose in children on regular dialysis. Am J Clin Nutr 31: 1865–1869

    Google Scholar 

  4. Schwalbe SL, Betts PR, Rayner PHW, Rudd BT (1977) Somatomedin in growth disorders and chronic renal insufficiency in children. BMJ 1: 679–682

    Google Scholar 

  5. Isaksson OGP, Jansson JO, Gause JAM (1982) Growth hormone stimulates longitudinal bone growth directly. Science 216: 1237–1239

    Google Scholar 

  6. Schoenle E, Zapf T, Foresch ER (1982) Insulin-like growth factor I stimulates growth in hypophysectomised rats. Nature 296: 252–253

    Google Scholar 

  7. Nilsson A, Carlsson B, Isgaard J, Isaksson OGP, Rymo L (1990) Regulation by GH of insulin-like growth factor-1 mRNA expression in rat epiphysial growth plate as studied with in-situ hybridization. J Endocrinol 125: 67–74

    Google Scholar 

  8. Baxter RC (1986) The somatomedins: insulin-like growth factors. Adv Clin Chem 25: 49–115

    Google Scholar 

  9. Baxter RC (1988) Characterisation of the acid-labile subunit of the growth hormone-dependent insulin-like growth factor binding protein complex. J Clin Endocrinol Metab 67: 265–272

    Google Scholar 

  10. Holly JMP, Wass JAH (1989) Insulin-like growth factors; autocrine, paracrine or endocrine? New perspectives of the somatomedin hypothesis in the light of recent developments. J Endocrinol 122: 611–618

    Google Scholar 

  11. Lynch RE, Furlanetto RW, Travis LB, Cunningham RJ, Mauer SM (1983) Serum Ria-somatomedin-C (Sm-C) is depressed in children and adolescents with end stage renal disease (abstract). Kidney Int 23: 217

    Google Scholar 

  12. Goldberg AC, Trivedi B, Delmez JA, Harter HR, Daughaday WH (1982) Uremia reduces serum insulin-like growth factor 1, increases insulin-like growth factor 11, and modifies their serum protein binding. J Clin Endocrinol Metab 55: 1040–1045

    Google Scholar 

  13. Powell DR, Rosenfeld RG, Baker BK, Liu F, Hintz RL (1986) Serum somatomedin levels in adults with chronic renal failure; the importance of measuring insulin-like growth factor 1 (IGF-1) and IGF-11 in acid chromatographed uraemic serum. J Clin Endocrinol Metab 63: 1186–1192

    Google Scholar 

  14. Powell DR, Rosenfeld RG, Sperry JB, Baker BK, Hintz RL (1988) Serum concentrations of insulin-like growth factor (IGF)-1, IGF-2 and unsaturated somatomedin carrier proteins in children with chronic renal failure. Am J Kidney Dis 10: 287–292

    Google Scholar 

  15. Blum WF, Ranke MB, Kietzmann K, Tönshoff B, Mehls O (1991) Growth hormone resistance and inhibition of somatomedin activity by excess of insulin-like growth factor binding protein in uraemia Pediatr Nephrol 5: 593–544

    Google Scholar 

  16. Andress DL, Pandian MR, Endres DB, Kopp JB (1989) Plasma insulin-like growth factors and bone formation in uraemic hyperparathyroidism. Kidney Int 36: 471–477

    Google Scholar 

  17. Lee PDK, Hintz RL, Sperry JB, Baxter RC, Powell DR (1989) IGF binding proteins in growth-retarded children with chronic renal failure. Pediatr Res 26: 308–315

    Google Scholar 

  18. Tönshoff B, Mehls O, Heinrich U, Blum WF, Ranke MB, Schauer A (1990) Growth-stimulating effects of recombinant human growth hormone in children with end-stage renal disease. J Pediatr 116: 561–566

    Google Scholar 

  19. Tönshoff B, Schaefer F, Mehls O (1990) Disturbance of growth hormone-insulin-like growth factor axis in uraemia. Implications for recombinant human growth hormone treatment. Pediatr Nephrol 4: 654–662

    Google Scholar 

  20. Schwartz GJ, Haycock GB, Edelman CM Jr, Spitzer A (1976) A simple estimate of glomerular filtration rate in children derived from body length and plasma creatinine. Pediatrics 58: 259–263

    Google Scholar 

  21. Tanner JM, Whitehouse RH, Takaishi M (1966) Standards from birth to maturity for height, weight, height velocity and weight velocity; British children 1965. Arch Dis Child 41: 613–635

    Google Scholar 

  22. Donath A (1971) The simultaneous determination in children of glomerular filtration rate and effective renal plasma flow by the single injection clearance technique. Acta Paediatr Scand 60: 512–420

    Google Scholar 

  23. Gruelich WW, Pyle S (1959) Radiographic atlas of skeletal development of the hand and wrist, 2nd edn. Stanford University Press, California.

    Google Scholar 

  24. Tanner JM, Whitehouse RH (1975) Revised standards for triceps and subscapular skinfolds in British children. Arch Dis Child 50: 142–145

    Google Scholar 

  25. Tanner JM (1962) Growth at adolescence, 2nd edn. Blackwell, Oxford

    Google Scholar 

  26. West CD, Smith WC (1956) An attempt to elucidate the cause of growth retardation in renal disease. Am J Dis Child 91: 460–476

    Google Scholar 

  27. Frisancho R (1981) New norms of upper limb fat and muscle areas for assessment of nutritional status. Am J Clin Nutr 34: 2540–2545

    Google Scholar 

  28. Baxter RC, Brown AS, Turtle JR (1982) Radioimmunoassay for somatomedin C: comparison with radioreceptor assay in patients with growth-hormone disorders, hypothyroidism and renal failure. Clin Chem 28: 488–494

    Google Scholar 

  29. Baxter RC, Brown AS (1982) Purification of tracer for somatomedin C radioimmunoassay by hydrophobic interaction chromatography. Clin Chem 28: 485–487

    Google Scholar 

  30. Daughaday WH, Mariz IK, Blethen SL (1980) Inhibition of access of bound somatomedin to membrane receptor and immunobinding sites: a comparison of radioreceptor and radioimmunoassay of somatomedin in native and acid-ethanol-extracted serum. J Clin Eudocrinol Metab 51: 781–788

    Google Scholar 

  31. Baxter RC, Martin JF (1986) Radioimmunoassay for growth-hormone dependent insulin-like growth factor binding protein in human plasma. J Clin Invest 78: 1504–1512

    Google Scholar 

  32. Hall K, Sara V (1984) Somatomedin levels in childhood, adolescence and adults. Clin Endocrinol Metab 13: 91–112

    Google Scholar 

  33. Daughaday WH, Kapadia M, Mariz I (1987) Serum somatomedin binding proteins: physiologic significance and interference in radioligand assay. J Lab Clin Med 109: 355–363

    Google Scholar 

  34. Liu F, Powell DR, Hintz RL (1990) Characterisation of insulin-like growth factor-binding proteins in human serum from patients with chronic renal failure. J Clin Endocrinol Metab 70: 620–628

    Google Scholar 

  35. Saenger P, Wiedemann E, Schwartz E, Korth-Schutz S, Lewy JE, Riggio RR, Rubin AL, Stenzel KH, New MI (1974) Somatomedin and growth after renal transplantation. Pediatr Res 8: 163–169

    Google Scholar 

  36. Burch WM, Correa J, Shively JE, Powell DR (1990) The 25-kilodalton insulin-like growth factor (IGF)-binding protein inhibits both basal and IGF-1 mediated growth of chick embryo pelvic cartilage in vitro. J Clin Endocrinol Metab 70: 173–180

    Google Scholar 

  37. Siloman AT, Hassan AI, Aref MK, Hintz RL, Rosenfeld RG, Rogol AD (1986) Serum insulin-like growth factors 1 and 11 concentrations and growth hormone and insulin responses to arginine infusion in children with protein-energy malnutrition before and after nutritional rehabilitation. Pediatr Res 11: 1122–1130

    Google Scholar 

  38. Powell DR, Rosenfeld RG, Hintz RL (1988) Effects of growth normone therapy and malnutrition on the growth of rats with renal failure. Pediatr Nephrol 2: 425–430

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Hodson, E.M., Brown, A.S., Roy, L.P. et al. Insulin-like growth factor-1, growth hormone-dependent insulin-like growth factor-binding protein and growth in children with chronic renal failure. Pediatr Nephrol 6, 433–438 (1992). https://doi.org/10.1007/BF00874005

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00874005

Key words

  • Insulin-like growth factor-1
  • Insulin-like growth factor-binding protein-3
  • Chronic renal failure
  • Growth retardation